| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $624.9M | $507.0M | $676.2M |
| YoY Revenue Growth % | +23.3% | -25.0% | — |
| Gross Profit | $437.3M | $351.8M | — |
| Gross Margin % | 70.0% | 69.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$46.4M | -$24.5M | -$283.0M |
| Operating Margin % | -7.4% | -4.8% | -41.9% |
| Net Income (GAAP) | -$13.9M | $27.3M | -$223.0M |
| EBITDA (Normalized) | -$45.0M | -$22.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $162.6M | $58.2M | $21.1M |
| Capital Expenditures (CapEx) | $1.8M | $2.4M | — |
| Free Cash Flow (FCF) | $160.8M | $55.8M | $21.1M |
| FCF Margin % | 25.7% | 11.0% | 3.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -11.9% | — |
| Cash & Short-Term Equivalents | $709.4M | $923.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $762.0M | $1.09B | — |